v1
Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
Identifier:nobleid.org/w1/20260515/CAF9C0CD
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/CAF9C0CD)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →